These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31084378)

  • 1. Addressing guideline and policy changes during pragmatic clinical trials.
    Curtis LH; Dember LM; Vazquez MA; Murray D; DeBar L; Staman KL; Septimus E; Mor V; Volandes A; Wells BL; Huang SS; Green BB; Coronado G; Meyers CM; Tuzzio L; Hernandez AF; Sugarman J
    Clin Trials; 2019 Aug; 16(4):431-437. PubMed ID: 31084378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical challenges in the conduct of pragmatic trials embedded in health plans: Lessons of IMPACT-AFib, an FDA-Catalyst trial.
    Garcia CJ; Haynes K; Pokorney SD; Lin ND; McMahill-Walraven C; Nair V; Parlett L; Martin D; Al-Khalidi HR; McCall D; Granger CB; Platt R; Cocoros NM
    Clin Trials; 2020 Aug; 17(4):360-367. PubMed ID: 32589056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.
    Lipman PD; Loudon K; Dluzak L; Moloney R; Messner D; Stoney CM
    Trials; 2017 Nov; 18(1):532. PubMed ID: 29126437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical Issues in Pragmatic Cluster-Randomized Trials in Dialysis Facilities.
    Goldstein CE; Weijer C; Taljaard M; Al-Jaishi AA; Basile E; Brehaut J; Cook CL; Grimshaw JM; Lacson E; Lindsay C; Jardine M; Dember LM; Garg AX
    Am J Kidney Dis; 2019 Nov; 74(5):659-666. PubMed ID: 31227227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stakeholders' views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs.
    Kalkman S; van Thiel GJ; Grobbee DE; Meinecke AK; Zuidgeest MG; van Delden JJ;
    Trials; 2016 Aug; 17(1):419. PubMed ID: 27550379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA-Catalyst-Using FDA's Sentinel Initiative for large-scale pragmatic randomized trials: Approach and lessons learned during the planning phase of the first trial.
    Cocoros NM; Pokorney SD; Haynes K; Garcia C; Al-Khalidi HR; Al-Khatib SM; Archdeacon P; Goldsack JC; Harkins T; Lin ND; Martin D; McCall D; Nair V; Parlett L; Temple R; McMahill-Walraven C; Granger CB; Platt R
    Clin Trials; 2019 Feb; 16(1):90-97. PubMed ID: 30445835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pragmatic clinical trials at the National Institute of Nursing Research.
    Littleton-Kearney M
    Nurs Outlook; 2018 Sep; 66(5):470-472. PubMed ID: 29699773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to participate in pragmatic dialysis trials: the importance of physician decisional autonomy and consent approach.
    Courtright KR; Halpern SD; Joffe S; Ellenberg SS; Karlawish J; Madden V; Gabler NB; Szymanski S; Yadav KN; Dember LM
    Trials; 2017 Oct; 18(1):474. PubMed ID: 29020994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis.
    Edmonston DL; Isakova T; Dember LM; Brunelli S; Young A; Brosch R; Beddhu S; Chakraborty H; Wolf M
    Am J Kidney Dis; 2021 Jun; 77(6):920-930.e1. PubMed ID: 33279558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing a framework for the ethical design and conduct of pragmatic trials in healthcare: a mixed methods research protocol.
    Taljaard M; Weijer C; Grimshaw JM; Ali A; Brehaut JC; Campbell MK; Carroll K; Edwards S; Eldridge S; Forrest CB; Giraudeau B; Goldstein CE; Graham ID; Hemming K; Hey SP; Horn AR; Jairath V; Klassen TP; London AJ; Marlin S; Marshall JC; McIntyre L; McKenzie JE; Nicholls SG; Alison Paprica P; Zwarenstein M; Fergusson DA
    Trials; 2018 Sep; 19(1):525. PubMed ID: 30261933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The APPROACH trial: Assessing pain, patient-reported outcomes, and complementary and integrative health.
    Zeliadt SB; Coggeshall S; Thomas E; Gelman H; Taylor SL
    Clin Trials; 2020 Aug; 17(4):351-359. PubMed ID: 32522024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stakeholder views regarding ethical issues in the design and conduct of pragmatic trials: study protocol.
    Nicholls SG; Carroll K; Brehaut J; Weijer C; Hey SP; Goldstein CE; Zwarenstein M; Graham ID; McKenzie JE; McIntyre L; Jairath V; Campbell MK; Grimshaw JM; Fergusson DA; Taljaard M
    BMC Med Ethics; 2018 Nov; 19(1):90. PubMed ID: 30458809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH Collaboratory.
    Weinfurt KP; Hernandez AF; Coronado GD; DeBar LL; Dember LM; Green BB; Heagerty PJ; Huang SS; James KT; Jarvik JG; Larson EB; Mor V; Platt R; Rosenthal GE; Septimus EJ; Simon GE; Staman KL; Sugarman J; Vazquez M; Zatzick D; Curtis LH
    BMC Med Res Methodol; 2017 Sep; 17(1):144. PubMed ID: 28923013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the Explanatory or Pragmatic Nature of Cardiovascular Clinical Trials Over 2 Decades.
    Sepehrvand N; Alemayehu W; Das D; Gupta AK; Gouda P; Ghimire A; Du AX; Hatami S; Babadagli HE; Verma S; Kashour Z; Ezekowitz JA
    JAMA Cardiol; 2019 Nov; 4(11):1122-1128. PubMed ID: 31473763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pragmatic study designs for older adults with cancer: Report from the U13 conference.
    Nipp RD; Yao NA; Lowenstein LM; Buckner JC; Parker IR; Gajra A; Morrison VA; Dale W; Ballman KV
    J Geriatr Oncol; 2016 Jul; 7(4):234-41. PubMed ID: 27197914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of pragmatic trials found a high degree of diversity in design and scope, deficiencies in reporting and trial registry data, and poor indexing.
    Nicholls SG; Carroll K; Hey SP; Zwarenstein M; Zhang JZ; Nix HP; Brehaut JC; McKenzie JE; McDonald S; Weijer C; Fergusson DA; Taljaard M
    J Clin Epidemiol; 2021 Sep; 137():45-57. PubMed ID: 33789151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders.
    Nicholls SG; Carroll K; Zwarenstein M; Brehaut JC; Weijer C; Hey SP; Goldstein CE; Graham ID; Grimshaw JM; McKenzie JE; Fergusson DA; Taljaard M;
    Trials; 2019 Dec; 20(1):765. PubMed ID: 31870433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported outcomes and target effect sizes in pragmatic randomized trials in ClinicalTrials.gov: A cross-sectional analysis.
    Vanderhout S; Fergusson DA; Cook JA; Taljaard M
    PLoS Med; 2022 Feb; 19(2):e1003896. PubMed ID: 35134080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.